Ostarine is definitely the closest SARM to remaining approved in medication which is currently in phase II clinical trials. Like SARMs generally speaking, MK-2866 targets androgen receptors on a selective basis and avoids producing the varieties of dangerous side effects associated with substances like testosterone, human growth hormone, or anabolic https://alcuins848jvg7.oneworldwiki.com/user